Gene · 3660
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of inositol polyphosphate-4-phosphatase type II in oncogenesis of digestive system tumors. | World J Gastrointest Oncol | 2023 | 37969410 | PubTator, text mining | PubMed |
| Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC). | J Transl Med | 2023 | 37968714 | PubTator, text mining | PubMed |
| Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets. | Nat Commun | 2023 | 37968278 | PubTator, text mining | PubMed |
| LEF1 isoforms regulate cellular senescence and aging. | Aging Cell | 2023 | 37961030 | PubTator, text mining | PubMed |
| New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases. | Nutrients | 2023 | 37960237 | PubTator, text mining | PubMed |
| Prognostic significance of serum miR-18a-5p in severe COVID-19 Egyptian patients. | J Genet Eng Biotechnol | 2023 | 37953403 | PubTator, text mining | PubMed |
| Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. | Front Oncol | 2023 | 37941546 | PubTator, text mining | PubMed |
| The role of pyroptosis-related genes in the diagnosis and subclassification of sepsis. | PLoS One | 2023 | 37939116 | PubTator, text mining | PubMed |
| CAR Gene Delivery by T-cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms. | Adv Sci (Weinh) | 2023 | 37904721 | PubTator, text mining | PubMed |
| Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer. | Cancers (Basel) | 2023 | 37894457 | PubTator, text mining | PubMed |
| IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance. | Sci Adv | 2023 | 37889967 | PubTator, text mining | PubMed |
| Novel frameshift variants expand the map of the genetic defects in IRF2BP2. | Front Immunol | 2023 | 37876937 | PubTator, text mining | PubMed |
| Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells. | Front Immunol | 2023 | 37868997 | PubTator, text mining | PubMed |
| Genetic susceptibility to post-endoscopic retrograde cholangiopancreatography pancreatitis identified in propensity score-matched analysis. | Korean J Intern Med | 2023 | 37867141 | PubTator, text mining | PubMed |
| Molecular genetic aberrations in the pathogenesis of multiple myeloma. | Asian Biomed (Res Rev News) | 2023 | 37860676 | PubTator, text mining | PubMed |
| Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment. | Nat Immunol | 2023 | 37845489 | PubTator, text mining | PubMed |
| A hub gene signature as a therapeutic target and biomarker for sepsis and geriatric sepsis-induced ARDS concomitant with COVID-19 infection. | Front Immunol | 2023 | 37822934 | PubTator, text mining | PubMed |
| Human inborn errors of immunity associated with IRF4. | Front Immunol | 2023 | 37809068 | PubTator, text mining | PubMed |
| Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma. | J Exp Clin Cancer Res | 2023 | 37803433 | PubTator, text mining | PubMed |
| Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy. | Arthritis Res Ther | 2023 | 37794420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3660/papers?page=8